Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

3.1900

-0.1550

(-4.63%)

At close: 04:00PM EDT

3.1900

0.00

(0.00%)

After hours:

05:04PM EDT

Major holders

Insider roster

Insider transactions

Currency in USD

Insider purchases - Last 6 months	Shares	Trans
Purchases	0	0
Sales	N/A	0
Net shares purchased (sold)	0	0
Total insider shares held	26.82M	N/A
% net shares purchased (sold)	N/A	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
RIZVI SYED ALI-AAMIR M.D. Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Apr 2024	185,000
LEONHARDT HARRY J. ESQ. General Counsel	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2024	80,743
MYLET JOHANNA Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2024	80,743
WARNER BRENT Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2024	80,743
GERGEN MARK J Officer and Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	02 Jan 2024	125,000
YAREMA KRISTIN Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	02 Jan 2024	250,000
LLOYD MARCEA BLAND Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 Jun 2023	19,650
COLLINS CYNTHIA Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 Jun 2023	19,650
SCHMID JOHN P Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 Jun 2023	19,650
BAUM CHARLES M Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 Jun 2023	19,650
CORNING LUKE Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	15 Jun 2023	19,650
AMADO RAFAEL Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 May 2023	39,300
YAREMA KRISTIN Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	11 Apr 2023	356,836
LEONHARDT HARRY J. ESQ. General Counsel	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2023	92,772
GERGEN MARK J Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2023	269,586
MYLET JOHANNA Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2023	92,772
WARNER BRENT Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2023	92,772
MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.50 per share.	Direct	7,525,000	08 Aug 2022	2,150,000
OSTERTAG ERIC Officer, Director and Beneficial Owner	Purchase at price 3.50 per share.	Direct	500,000	08 Aug 2022	142,857
OSTERTAG ERIC Officer, Director and Beneficial Owner	Sale at price 3.69 per share.	Indirect	592,808	03 Aug 2022	160,696
LLOYD MARCEA BLAND Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	16 Jun 2022	19,650
COLLINS CYNTHIA Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	16 Jun 2022	19,650
SCHMID JOHN P Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	16 Jun 2022	19,650
BAUM CHARLES M Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	16 Jun 2022	39,300
CORNING LUKE Director	Stock Award(Grant) at price 0.00 per share.	Direct	0	16 Jun 2022	19,650
INGALLS KERRY D Chief Operating Officer	Purchase at price 3.98 per share.	Direct	11,940	16 Mar 2022	3,000
LEONHARDT HARRY J. ESQ. General Counsel	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2022	50,000
INGALLS KERRY D Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2022	50,000
MYLET JOHANNA Chief Financial Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2022	50,000
SPEAR MATTHEW A. Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2022	50,000
WARNER BRENT Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Mar 2022	307,881
GERGEN MARK J Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Feb 2022	357,200
OSTERTAG ERIC Officer, Director and Beneficial Owner	Stock Award(Grant) at price 0.00 per share.	Direct	0	01 Feb 2022	89,500
OSTERTAG ERIC Officer, Director and Beneficial Owner	Stock Gift at price 0.00 per share.	Indirect	0	30 Dec 2021	142,857
MYLET JOHANNA Chief Financial Officer	Conversion of Exercise of derivative security at price 1.17 - 1.93 per share.	Direct	9,061	21 Dec 2021	5,716
MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.90 per share.	Direct	12,613	06 Dec 2021	1,828
SPEAR MATTHEW A. Officer	Conversion of Exercise of derivative security at price 1.32 per share.	Direct	13,220	06 Dec 2021	10,000
MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.85 - 6.88 per share.	Direct	351,194	02 Dec 2021	51,253
MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.81 - 6.89 per share.	Direct	268,962	29 Nov 2021	39,362
MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.77 - 7.44 per share.	Direct	181,640	23 Nov 2021	25,729
OSTERTAG ERIC Chief Executive Officer	Conversion of Exercise of derivative security at price 9.15 per share.	Direct	9,150	19 Nov 2021	1,000
MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.17 - 7.21 per share.	Direct	2,731,889	18 Nov 2021	379,376
INGALLS KERRY D Chief Operating Officer	Purchase at price 7.00 per share.	Direct	14,000	17 Nov 2021	2,000
OSTERTAG ERIC Chief Executive Officer	Sale at price 7.09 per share.	Indirect	134,171	08 Nov 2021	18,924
OSTERTAG ERIC Chief Executive Officer	Conversion of Exercise of derivative security at price 9.15 per share.	Direct	169,504	11 Oct 2021	18,525
OSTERTAG ERIC Chief Executive Officer	Sale at price 7.02 per share.	Indirect	140,604	01 Oct 2021	20,029
OSTERTAG ERIC Chief Executive Officer	Sale at price 8.00 per share.	Indirect	160,020	20 Sept 2021	20,000
OSTERTAG ERIC Chief Executive Officer	Sale at price 8.14 per share.	Indirect	162,712	14 Sept 2021	20,000
OSTERTAG ERIC Chief Executive Officer	Conversion of Exercise of derivative security at price 1.17 - 9.15 per share.	Direct	172,729	13 Sept 2021	21,281
SPEAR MATTHEW A. Officer	Conversion of Exercise of derivative security at price 1.32 per share.	Direct	13,220	09 Sept 2021	10,000
OSTERTAG ERIC Chief Executive Officer	Sale at price 8.34 - 8.46 per share.	Indirect	943,646	02 Sept 2021	112,411
SPEAR MATTHEW A. Officer	Sale at price 8.79 per share.	Direct	35,142	20 Aug 2021	4,000
SPEAR MATTHEW A. Officer	Conversion of Exercise of derivative security at price 1.32 per share.	Direct	5,288	20 Aug 2021	4,000
OSTERTAG ERIC Chief Executive Officer	Conversion of Exercise of derivative security at price 9.15 per share.	Direct	1,017,013	06 Aug 2021	111,149
OSTERTAG ERIC Chief Executive Officer	Sale at price 7.99 - 8.13 per share.	Indirect	270,970	03 Aug 2021	33,673
SPEAR MATTHEW A. Officer	Conversion of Exercise of derivative security at price 1.32 per share.	Direct	26,440	28 Jul 2021	20,000
OSTERTAG ERIC Chief Executive Officer	Sale at price 8.90 - 9.77 per share.	Indirect	446,174	02 Jul 2021	48,105
SPEAR MATTHEW A. Officer	Conversion of Exercise of derivative security at price 1.32 per share.	Direct	6,610	17 Jun 2021	5,000
SPEAR MATTHEW A. Officer	Sale at price 9.44 per share.	Direct	37,747	11 Jun 2021	4,000
SPEAR MATTHEW A. Officer	Conversion of Exercise of derivative security at price 1.32 per share.	Direct	5,288	11 Jun 2021	4,000
OSTERTAG ERIC Chief Executive Officer	Sale at price 8.34 - 8.61 per share.	Indirect	694,302	02 Jun 2021	81,916
OSTERTAG ERIC Chief Executive Officer	Sale at price 8.44 - 9.01 per share.	Indirect	468,839	04 May 2021	54,312
SPEAR MATTHEW A. Officer	Conversion of Exercise of derivative security at price 1.32 per share.	Direct	11,898	23 Apr 2021	9,000
SPEAR MATTHEW A. Officer	Sale at price 8.44 per share.	Direct	33,752	21 Apr 2021	4,000
OSTERTAG ERIC Chief Executive Officer	Sale at price 9.55 - 10.32 per share.	Indirect	1,104,998	05 Apr 2021	115,000
OSTERTAG ERIC Chief Executive Officer	Sale at price 11.54 - 12.12 per share.	Indirect	1,334,461	02 Mar 2021	115,000
OSTERTAG ERIC Chief Executive Officer	Conversion of Exercise of derivative security at price 1.17 per share.	Direct	130,666	23 Feb 2021	111,395
OSTERTAG ERIC Chief Executive Officer	Sale at price 10.00 per share.	Indirect	1,332,036	16 Feb 2021	133,149
OSTERTAG ERIC Chief Executive Officer	Sale at price 10.00 per share.	Indirect	123,890	10 Feb 2021	12,389
OSTERTAG ERIC Chief Executive Officer	Conversion of Exercise of derivative security at price 1.29 per share.	Direct	87,119	10 Feb 2021	67,534
OSTERTAG ERIC Chief Executive Officer	Sale at price 10.00 per share.	Indirect	44,620	21 Jan 2021	4,462
MYLET JOHANNA Officer	Conversion of Exercise of derivative security at price 0.30 per share.	Direct	1,418	15 Jan 2021	4,728
SPEAR MATTHEW A. Officer	Conversion of Exercise of derivative security at price 1.32 per share.	Direct	10,000	15 Jan 2021	7,564
SPEAR MATTHEW A. Officer	Conversion of Exercise of derivative security at price 1.32 per share.	Direct	5,184	08 Jan 2021	3,921
LLOYD MARCEA BLAND Director	Purchase at price 13.01 per share.	Direct	130,100	14 Jul 2020	10,000
HIRSCH DAVID Director	Purchase at price 13.01 per share.	Indirect	3,252,500	14 Jul 2020	250,000
HIRSCH DAVID Director		Indirect		14 Jul 2020	2,464,245
MURPHY SEAN EDWARD Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 13.01 per share.	Direct	130,100	14 Jul 2020	10,000
MURPHY SEAN EDWARD Director and Beneficial Owner of more than 10% of a Class of Security		Indirect		14 Jul 2020	9,188,125
MALIN LIFE SCIENCES HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security		Indirect		14 Jul 2020	9,188,125
NOVARTIS PHARMA AG Beneficial Owner of more than 10% of a Class of Security		Direct		14 Jul 2020	5,908,089
OSTERTAG ERIC Chief Executive Officer		Indirect		14 Jul 2020	606,541

NZX 5011,735.71+35.92(+0.31%)

NZD/USD0.6124-0.0012(-0.20%)

ALL ORDS8,132.10+49.80(+0.62%)

OIL79.73-0.33(-0.41%)

GOLD2,446.30+28.90(+1.20%)

Poseida Therapeutics, Inc. (PSTX)

Insider transactions

Insider transactions reported - last two years

NZX 50
11,735.71
+35.92(+0.31%)

NZD/USD
0.6124
-0.0012(-0.20%)

ALL ORDS
8,132.10
+49.80(+0.62%)

OIL
79.73
-0.33(-0.41%)

GOLD
2,446.30
+28.90(+1.20%)